乐普医疗
(300003)
| 流通市值：180.79亿 | | | 总市值：211.07亿 |
| 流通股本：15.79亿 | | | 总股本：18.43亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 3,214,194,092.31 | 1,672,061,164 | 6,482,731,703.55 | 4,938,709,224.18 |
| 营业总成本 | 2,744,393,418.86 | 1,409,787,783.97 | 5,250,530,600.6 | 3,806,841,489.27 |
| 其他经营收益 | | | | |
| 营业利润 | 497,098,650.81 | 264,525,667.41 | 1,220,070,429.34 | 1,176,449,780.67 |
| 利润总额 | 484,982,806.75 | 258,788,541.83 | 1,216,078,125.9 | 1,159,315,259.6 |
| 净利润 | 456,594,901.56 | 223,193,386.63 | 1,019,003,602.25 | 995,994,270.25 |
| 每股收益 | | | | |
| 其他综合收益 | 95,706,565.98 | 73,949,750.34 | 351,080,547.85 | 161,148,244.62 |
| 综合收益总额 | 552,301,467.54 | 297,143,136.97 | 1,370,084,150.1 | 1,157,142,514.87 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 9,554,448,335.64 | 9,232,676,386.96 | 9,995,802,449.38 | 9,488,548,168.96 |
| 非流动资产: | | | | |
| 非流动资产合计 | 16,618,094,873.69 | 16,354,314,779.04 | 16,142,862,225.25 | 16,122,611,114.71 |
| 资产总计 | 26,172,543,209.33 | 25,586,991,166 | 26,138,664,674.63 | 25,611,159,283.67 |
| 流动负债: | | | | |
| 流动负债合计 | 4,180,823,743.48 | 3,881,060,811.81 | 4,963,679,424.71 | 5,012,926,589.74 |
| 非流动负债: | | | | |
| 非流动负债合计 | 4,128,549,382.16 | 3,730,155,113.35 | 3,415,268,527.95 | 2,853,216,538.59 |
| 负债合计 | 8,309,373,125.64 | 7,611,215,925.16 | 8,378,947,952.66 | 7,866,143,128.33 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 16,397,670,089.36 | 16,439,871,448.11 | 16,115,076,562.31 | 16,033,829,824.38 |
| 股东权益合计 | 17,863,170,083.69 | 17,975,775,240.84 | 17,759,716,721.97 | 17,745,016,155.34 |
| 负债和股东权益合计 | 26,172,543,209.33 | 25,586,991,166 | 26,138,664,674.63 | 25,611,159,283.67 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,130,403,950.44 | 1,504,272,127.44 | 6,563,538,818.31 | 4,791,864,933.04 |
| 经营活动现金流出小计 | 2,497,835,140.53 | 1,229,370,830.81 | 5,046,618,141.58 | 3,779,187,903.72 |
| 经营活动产生的现金流量净额 | 632,568,809.91 | 274,901,296.63 | 1,516,920,676.73 | 1,012,677,029.32 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 768,341,281.1 | 428,908,953.47 | 1,064,312,992.07 | 706,991,100.09 |
| 投资活动现金流出小计 | 955,217,467.69 | 473,502,662.31 | 1,755,053,744.52 | 1,424,902,772.85 |
| 投资活动产生的现金流量净额 | -186,876,186.59 | -44,593,708.84 | -690,740,752.45 | -717,911,672.76 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,465,423,667.52 | 1,333,185,161 | 3,522,068,907.19 | 2,136,526,157.99 |
| 筹资活动现金流出小计 | 3,141,652,685.35 | 2,339,671,946.3 | 3,604,425,776.04 | 2,484,472,230.33 |
| 筹资活动产生的现金流量净额 | -676,229,017.83 | -1,006,486,785.3 | -82,356,868.85 | -347,946,072.34 |
| 汇率变动对现金及现金等价物的影响 | -38,593,082.3 | -21,892,079.91 | -16,782,077.52 | -4,056,544.29 |
| 现金及现金等价物净增加额 | -269,129,476.81 | -798,071,277.42 | 727,040,977.91 | -57,237,260.07 |
| 期末现金及现金等价物余额 | 4,072,311,136.52 | 3,543,369,335.91 | 4,341,440,613.33 | 3,557,162,375.35 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -269,129,476.81 | - | 727,040,977.91 | - |
最新报告期：2026-08-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中泰证券 | 祝嘉琦,谢木青 | 0.46 | 0.58 | 0.69 | 2026-08-30 |